Cancer ghosting is when a friend, acquaintance or family member who was present in a person’s life before a cancer diagnosis disappears without explanation, leaving feelings of sadness and anxiety for ...

The administration’s fiscal year 2026 proposed budget included devastating cuts to the National Institutes of Health (NIH) ...

LOS ANGELES, CALIF. – (July 2, 2025) – The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to fighting pancreatic cancer, today announced a new data partnership ...

Editor’s Note: May is Asian American and Pacific Islander (AAPI) Heritage Month, an opportunity to commemorate the rich and diverse cultures, traditions and accomplishments of Asian Americans and ...

Each year, the National Cancer Institute (NCI) shares critical updates on the state of cancer in the United States. In the latest Annual Report to the Nation on the Status of Cancer, there is good ...

Editor’s note: In this heartfelt interview, Jaylen Baron shares the story of her mother, Jane – an inspiring dance teacher, mentor and fighter – whose legacy is honored every year at PanCAN ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights about the latest news ...

Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients LOS ANGELES, Calif. – (January 16, 2025) – After ...

LOS ANGELES, Calif. (November 1, 2024) – The Pancreatic Cancer Action Network (PanCAN) is highlighting the importance of early detection of pancreatic cancer and knowing the risks and symptoms as part ...

PanCAN’s new Chief Scientific and Medical Officer, Anna Berkenblit, MD, MMSc, has nearly 20 years of experience bringing new therapies to patients with cancer. She’s served in leadership roles in ...

For the first time in more than a decade, the FDA has approved a new first-line treatment for patients with metastatic pancreatic cancer. After a clinical trial showed a positive survival benefit, the ...